News | March 13, 2022
Japan tops CPhI ‘API Quality’ ranking for second year
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Tislelizumab is now approved for seven indications in China
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
The money will be donated to the United Nations Children’s Fund (UNICEF)
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Subscribe To Our Newsletter & Stay Updated
